3,4-dihydroxyacetophenone inhibits hypoxia-associated human 2+ pulmonary artery smooth muscle cell proliferation by reducing Ca influx | [Pakistan Journal of Pharmaceutical Sciences • 2021]

Author(s):

1. Chunlong Lin: Department of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology,Yueyang, Hunan,China

2. Caixia Li: Department of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology,Yueyang, Hunan,China

3. Jianping Zhao: Department of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology,Yueyang, Hunan,China

4. Wang Ni: Department of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology,Yueyang, Hunan,China

5. Jizu Yi: Department of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology,Yueyang, Hunan,China

Abstract:

The present study aimed to assess the effects of 3,4-dihydroxyacetophenone (DHAP) on human pulmonary artery smooth muscle cells (HPASMCs). HPASMCs were divided into the normoxia group (NG), hypoxia group (HG), and hypoxia and 0.6×10-4 mol/L (HD1), 1.9×10-4 mol/L (HD2) and 6.0×10-4 mol/L (HD3) DHAP treatment groups. Cell cycle was analyzed by flow-cytometrically. HPASMC growth was examined by the proliferating cell nuclear antigen (PCNA) and MTT assays. Intracellular Ca2+ ([Ca2+]i) was measured by laser scanning confocal microscopy. Compared with the NG, the HG showed significantly increased HPASMC proliferation (P<0.05); meanwhile, cells treated with DHAP showed decreased proliferation compared with the HG (P<0.05). Hypoxia enhanced cell cycle progression and DHAP partly restored cell cycle distribution toward the status of NG cells. Furthermore, CDK2 levels were markedly increased in hypoxic cells (P<0.05), while DHAP treatment starkly decreased CDK2 levels in comparison with the HG (P<0.05). Moreover, hypoxia increased intracellular [Ca2+] levels compared with normoxia (P<0.05); meanwhile, DHAP treatment decreased [Ca2+]i compared with the HG (P<0.05). These findings suggested that DHAP inhibits hypoxiainduced proliferation of HPASMCs involving [Ca2+]i reduction. Therefore, DHAP should be considered an ideal candidate for the prevention and/or treatment of hypoxia-associated pulmonary hypertension and pulmonary vascular remodeling.

Page(s): 157-163

DOI: DOI not available

Published: Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: 1, Year: 2021

Keywords:

Hypoxia , Hypoxia , pulmonary hypertension , pulmonary artery smooth muscle cell , cell cycle , pulmonary vascular remodeling , 4dihydroxyacetophenone

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views